Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.
- DOI
- 10.1177/20406223241247643
- Published
- 2024
- Container
- Therapeutic advances in chronic disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/20406223241247643,
title = {Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.},
author = {Boot AM and Ariceta G and Beck-Nielsen SS and Brandi ML and Briot K and Collantes CL and Giannini S and Haffner D and Keen R and Levtchenko E and Mughal MZ and Mäkitie O and Nilsson O and Schnabel D and Tripto-Shkolnik L and Zillikens MC and Liu J and Tudor A and Emma F},
year = {2024},
journal = {Therapeutic advances in chronic disease},
doi = {10.1177/20406223241247643},
url = {https://doi.org/10.1177/20406223241247643}
}RIS
TY - JOUR TI - Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis. AU - Boot AM AU - Ariceta G AU - Beck-Nielsen SS AU - Brandi ML AU - Briot K AU - Collantes CL AU - Giannini S AU - Haffner D AU - Keen R AU - Levtchenko E AU - Mughal MZ AU - Mäkitie O AU - Nilsson O AU - Schnabel D AU - Tripto-Shkolnik L AU - Zillikens MC AU - Liu J AU - Tudor A AU - Emma F PY - 2024 JO - Therapeutic advances in chronic disease DO - 10.1177/20406223241247643 UR - https://doi.org/10.1177/20406223241247643 ER -
APA
AM, B., G, A., SS, B., ML, B., K, B., CL, C., S, G., D, H., R, K., E, L., MZ, M., O, M., O, N., D, S., L, T., MC, Z., J, L., A, T., & F, E. (2024). Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.. Therapeutic advances in chronic disease. https://doi.org/10.1177/20406223241247643
Source records
- pubmed · retrieved 2026-09-26T21:48:10.405Z